Kura Oncology’s (NASDAQ:KURA) recently announced deal with Kirin Kyowa (OTCPK:KNBWY) for its leukemia drug ziftomenib was viewed favorably by analysts on Thursday, despite shares plunging 35% in ...

Kura Oncology (NASDAQ:KURA) stock slid 17% post-market after the company announced a collaboration deal with Japan's Kyowa Kirin (OTCPK:KNBWY) for its leukemia drug candidate ziftomenib worth up ...

In this article, we are going to take a look at where Kura Oncology, Inc. (NASDAQ:KURA) stands against the other promising cancer stocks. According to the World Health Organization (WHO), cancer ...

Jefferies analyst Roger Song maintained a Buy rating on Kura Oncology (KURA – Research Report) today and set a price target of $28.00. The company’s shares closed last Friday at $11.04.

Japan-based Kyowa Kirin is fronting $330 million and pledging up to $1.1 billion in milestones to split the U.S. profits of Kura Oncology’s phase 2-stage oral leukemia treatment as well as to ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Janux Therapeutics Inc (JANX – Research Report) and Kura Oncology (KURA – Research Report ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to take a look at where Kura Oncology, Inc. (NASDAQ:KURA) stands against the ...

In this article, we are going to take a look at where Kura Oncology, Inc. (NASDAQ:KURA) stands against the other small-cap biotech stocks. The biotechnology sector is expanding quickly due to rising ...

"We had some few challenges and that is why we could not finish as anticipated," KURA's, Resident Engineer Kenneth Mbogori said. "The construction is ongoing, we are now remaining with only 14 ...

Kura Revolving Sushi Bar is more like a casino. Or perhaps a Pachinko parlor, insofar as a Pachinko parlor resembles a casino, with its rows of glowing screens that chime out with bells ...